Zegalogue (Dasiglucagon)
- Medicine Name: Zegalogue
- Generic Name: Dasiglucagon
- Dosage Form & Strength: Injection: 0.6 mg/0.6 mL single-dose autoinjector and single-dose prefilled syringe
- Manufactured By: Zealand Pharma A/S
Zegalogue is an antihypoglycemic agent used for the treatment of very low blood sugar which is also known as severe hypoglycemia in pediatric and adult patients with diabetes aged six years and beyond.
Recommended Dosage: Zegalogue autoinjector and prefilled syringe are for subcutaneous use only. The proposed dose regimen for patients aged six years and older is 0.6 mg given by subcutaneous injection into the thigh, outer upper arm, buttocks, or lower abdomen.
In case there has been no reaction following 15 minutes, a surplus 0.6 mg dose from a new device may be given.
- The use of zegalogue 0.6 mg injection is not recommended in all those with pheochromocytoma because dasiglucagon may promote the dismission of catecholamines from the tumor. In case of a substantial increase in blood pressure and a previously undiagnosed pheochromocytoma, 5-10 mg of phentolamine mesylate, given intravenously, has been demonstrated to be useful in reducing blood pressure.
- In those with insulinoma, the use of glucagon products may cause an initial boost in blood glucose; however, the use of Zegalogue may directly or indirectly stimulate exaggerated insulin release from an insulinoma and cause hypoglycemia. Zegalogue is not for those with insulinoma. If signs of hypoglycemia occur after a Zegalogue dose, an oral or intravenous form of glucose can be considered.
- Allergic reactions may occur with glucagon products; these include generalized rash, and in some cases anaphylactic shock with breathing complications and hypotension. Patients should seek prompt medical assistance if they experience any signs of severe hypersensitivity reactions.
- Zegalogue is promising in treating hypoglycemia only in case apt hepatic glycogen exists. Those in scenarios of starvation, with chronic hypoglycemia, may not have appropriate levels of hepatic glycogen for Zegalogue use to be promising. Those with these conditions need to be treated with glucose.
What documents are required to import ZEGALOGUE to India?
ZEGALOGUE (dasiglucagon) injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID Proof (issued by the government of India)
The order will be confirmed only after the receipt of:
- A valid prescription from Doctor
- Import permit if applicable
ZEGALOGUE (dasiglucagon injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Zegalogue in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
IPN (Indian Pharma Network) can facilitate the supply of ZEGALOGUE (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Zegalogue injection price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the ZEGALOGUE (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma Network offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Zegalogue®?
Dasiglucagon is a Generic Name for the trade name drug Zegalogue®.
What is the Manufacturer’s Name of Zegalogue®?
Zegalogue® is manufactured by Zealand Pharma A/S.
Is Zegalogue® approved by the FDA?
Yes, Zegalogue® is approved by the FDA. Date of approval: March, 2021.
What is the dosage and form of Zegalogue® supplied?
Zegalogue® is supplied as Injection: 0.6 mg/0.6 mL single-dose autoinjector and single-dose prefilled syringe for subcutaneous use.
What are the most common side effects of Zegalogue®?
The most common side effects of Zegalogue® in adults are headache, nausea, vomiting, diarrhea, and injection site pain,
The most common side effects of Zegalogue® in pediatrics are headache, nausea, vomiting, and injection site pain.
How much does Zegalogue cost in India?
The zegalogue cost in India can vary. In order to procure this antihypoglycemic agent authentically, you can Call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Zegalogue®?
Store this medicine in a refrigerator, 2-8°C (36-46°F). Keep the medicine away from the cooling element. It is not advisable to freeze it.
Is it safe to buy Zegalogue® online in India?
Yes, you can buy Zegalogue in India at the best price from the Indian Pharma Network (IPN) if the drug Zegalogue has not been approved or is not available in your home country.
What are the Highlights of prescribing information for Zegalogue®?
Click Here to download full Zegalogue prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.